Clinical trials are research studies that evaluate new procedures or drugs, weighing their effectiveness against current, standard protocols. BIDMC investigators studying cancer help "translate" their laboratory discoveries into clinical trials that eventually lead to improved treatments that benefit patients here and elsewhere.
Our specialty programs participate in a wide range of Phase I through Phase IV studies that investigate new uses of FDA approved drugs as well as novel investigational agents. Because the Cancer Center at BIDMC is an integral part of a full service hospital, patients enrolled in clinical trials receive cohesive, patient-focused, comprehensive care.
The Cancer Center's acclaimed clinical researchers offer patients novel treatment options through a number of clinical trials. Through these special research studies, patients can access new, potentially more effective treatment options before they become more widely available.
Our patients benefit from BIDMC's membership in the Dana-Farber/Harvard Cancer Center, the largest cancer research consortium in the country. This provides them with access to a broad array of the most current clinical trials.
BIDMC physician-scientists participate in clinical trials in connection with:
